カンナビジオール(CBD)の世界市場調査レポート : 2030年までの予測

出版:Market Research Future(マーケットリサーチフューチャー) 出版年月:2023年4月

Global CBD Market Research Report Forecast to 2030
カンナビジオール(CBD)の世界市場調査レポート : 2030年までの予測

ページ数104
価格
シングルユーザライセンスUSD 4,950
エンタープライズライセンスUSD 7,250
種別英文調査報告書

レポート目次    お問合せ・ご注文    価格・納期について

無料サンプル

Cannabidiol Market Forecast till 2030
Market Overview

Cannabis plants contain cannabidiol (CBD), a non-addictive substance. The compound is found in cannabis in greater concentrations than tetrahydrocannabinol (THC). This industry consists of a variety of forms (solids, liquids) routes of administration (tinctures, capsules, inhalation (smoke or vapour), aerosol sprays) and products (food grade, therapeutic grade).
Cannabidiol, which does not produce psychoactive effects, is the most widely consumed of the cannabinoids. It has been found to be effective in treating a variety of conditions, including anxiety, depression, stress, diabetes, pain, cancer symptoms, and inflammation. This has led to an increase in demand for CBD oil, resulting in a large growth in the global market. This has prompted commercial retailers to invest more in CBD oil, as it offers high profit margins. Wellness and health retailers, such as CVS Health, Rite Aid, and Walgreens Boots Alliance have begun to offer products containing CBD oil.

Segment Overview
The global market has been segregated into form, product, route of administration, application, end user and regional segments. The global CBD market has been divided into Solid and Liquid. Considering on routes of administration, the global market of cannabidiol is divided into Tincture, Capsules, Inhalation, Aerosol Spray. According to the Product type the global market has been divided into Therapeutic Grade and Food Grade. Based on application, the global cannabidiol market is sub-segmented into Fibromyalgia, Diabetes, Protein Bars, Neurogenerative Disorder, Energy Drinks. The End User segment covers Food & Beverage and Healthcare, while Source segment includes Organic and Inorganic.

Regional Analysis
The worldwide Cannabidiol market has been concentrated across North America, Europe, Asia Pacific, and Rest of the World. Americas represented the biggest market portion in 2021. According to the WHO, about 147 million people around the world use marijuana and other cannabis-related products. Furthermore, 22.2 million Americans who use cannabis-based products are 12 years old or older. Europe has the second largest position of regional market in the cannabidiol. The use of CBD is legal on the European market. The Ministry of Agriculture, the Bulgarian Food Safety Agency and the Ministry of Agriculture have all approved the use of cannabidiol in Europe. These agencies have issued ‘free certificates of sale’ for CBD products. These legalizations and approvals are driving the European market’s growth. In Europe, the practice is legal, but there are some positive restrictions as well. Also, cannabis laws are different in various European countries. Various companies participating in the market are creating various opportunities and scope for development.
Major Players
Folium Biosciences, Aphria Inc., Elixinol Global Limited, LLC., Green Roads of Florida, Freedom Leaf Inc, CBD Health Solutions, CV Sciences, Isodiol International Inc, Canopy Growth Corporation and Medical Marijuana Inc. are among the leading companies operating in the global Cannabidiol (CBD) Market.
COVID 19 Impacts
The spread of the covid-19 virus has caused extraordinary lockdowns in industries around the world, disrupting and destroying many of their daily operations. This has caused retail stores to close, leading to a shortfall in the global market’s supply chain. The primary source of this disruption has been the shutdown of raw material-producing countries such as China and India. Moreover, the supply chain and production of cannabidiol-based products in the US has been severely impacted by the disruption of other raw material supplies.


目次

TABLE OF CONTENT
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION 17
2.2 SCOPE OF THE STUDY 17
2.3 MARKET STRUCTURE 18
3 RESEARCH METHODOLOGY
3.1 RESEARCH METHODOLOGY 19
3.2 PRIMARY RESEARCH 20
3.3 SECONDARY RESEARCH 21
3.4 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 22
3.5 FORECAST MODEL 22
4 MARKET DYNAMICS
4.1 INTRODUCTION 23
4.2 DRIVERS 24
4.2.1 GROWING RESEARCH AND DEVELOPMENT ACTIVITIES AND FINANCIAL SUPPORT BY VARIOUS PRIVATE AND
GOVERNMENT ORGANIZATIONS FOR CANNABINOID RESEARCH 24
4.2.2 RISING OCCURRENCE OF CHRONIC DISEASES AND RELATED COMPLICATIONS 24
4.2.3 LEGALIZATION OF CANNABINOID (CBD) IN VARIOUS REGIONS 24
4.3 RESTRAINTS 25
4.3.1 ADVERSE EFFECTS ASSOCIATED WITH CANNABIS 25
4.3.2 STRINGENT GOVERNMENT POLICIES 25
4.4 OPPORTUNITIES 25
4.4.1 IMPROVING STATUS OF CANNABIS IN ASIAN COUNTRIES 25
4.5 MEGATRENDS AND TECHNOLOGICAL ADVANCEMENTS 26
5 MARKET FACTOR ANALYSIS
5.1 SUPPLY CHAIN ANALYSIS 27
5.1.1 RESEARCH & DEVELOPMENT 27
5.1.2 MANUFACTURING 27
5.1.3 DISTRIBUTION AND SALES 28
5.1.4 POST-SALES MONITORING 28
5.2 PORTER’S FIVE FORCES MODEL 29
5.2.1 THREAT OF NEW ENTRANTS 29
5.2.2 BARGAINING POWER OF SUPPLIERS 30
5.2.3 BARGAINING POWER OF BUYERS 30
5.2.4 THREAT OF SUBSTITUTES 30
5.2.5 INTENSITY OF RIVALRY 30
5.3 ETOP ANALYSIS 31
5.3.1 THREAT 31
5.3.1.1 STRINGENT REGULATORY SCENARIO 31
5.3.2 OPPORTUNITIES 31
5.3.2.1 EXPLORING NEW APPLICATIONS 31
5.4 INVESTMENT OPPORTUNITY ANALYSIS 31
5.5 PRICING ANALYSIS 32
5.6 REGULATORY SCENARIO 32
6 CBD MARKET, BY FORM
6.1 INTRODUCTION 33
6.2 SOLID 34
6.3 LIQUID 34
7 CBD MARKET, BY ROUTES OF ADMINISTRATION
7.1 INTRODUCTION 35
7.2 TINCTURE 36
7.3 CAPSULES 36
7.4 INHALATION (SMOKE OR VAPOR) 37
7.5 AEROSOL SPRAY 37
8 CBD MARKET, BY PRODUCT
8.1 INTRODUCTION 38
8.2 FOOD GRADE 39
8.3 THERAPEUTIC GRADE 39
9 CBD MARKET, BY APPLICATION
9.1 INTRODUCTION 40
9.2 NEUROGENERATIVE DISORDER 41
9.3 FIBROMYALGIA 41
9.4 DIABETES 42
9.5 PROTEIN BARS 42
9.6 ENERGY DRINKS 42
10 CBD MARKET, BY END USE
10.1 INTRODUCTION 43
10.2 FOOD & BEVERAGE 44
10.3 HEALTHCARE 44
11 CBD MARKET, BY SOURCE
11.1 INTRODUCTION 45
11.2 ORGANIC 46
11.3 INORGANIC 46
12 GLOBAL CBD MARKET, BY REGION
12.1 INTRODUCTION 47
12.2 AMERICAS 49
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.2.1 NORTH AMERICA 51
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.2.1.1 US 53
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.2.1.2 CANADA 55
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.2.2 LATIN AMERICA 57
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.2.2.1 BRAZIL 59
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.2.2.2 REST OF LATIN AMERICA 61
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.3 EUROPE 64
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.3.1 WESTERN EUROPE 66
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.3.1.1 FRANCE 68
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.3.1.2 ITALY 70
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.3.1.3 GERMANY 72
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.3.1.4 UK 74
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.3.1.5 REST OF WESTERN EUROPE 76
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.3.2 EASTERN EUROPE 78
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.4 ASIA-PACIFIC 81
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.4.1 JAPAN 83
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.4.2 CHINA 85
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.4.3 INDIA 87
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.4.4 REST OF ASIA-PACIFIC 89
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
12.5 MIDDLE EAST & AFRICA 91
CBD MARKET, BY FORM
CBD MARKET, BY ROUTES OF ADMINISTRATION
CBD MARKET, BY PRODUCT
CBD MARKET, BY APPLICATION
CBD MARKET, BY END USE
CBD MARKET, BY SOURCE
13 COMPETITIVE LANDSCAPE
13.1 COMPETITIVE LANDSCAPE 94
14 COMPANY PROFILES
14.1 APHRIA INC. 97
14.1.1 COMPANY OVERVIEW 97
14.1.2 FINANCIAL OVERVIEW 97
14.1.3 PRODUCTS/SERVICES OFFERED 98
14.1.4 KEY DEVELOPMENTS 98
14.1.5 SWOT ANALYSIS 98
14.1.6 KEY STRATEGIES 99
14.2 FOLIUM BIOSCIENCES 100
14.2.1 COMPANY OVERVIEW 100
14.2.2 FINANCIAL OVERVIEW 100
14.2.3 PRODUCTS/SERVICES OFFERED 101
14.2.4 KEY DEVELOPMENTS 101
14.2.5 SWOT ANALYSIS 102
14.2.6 KEY STRATEGIES 102
14.3 FREEDOM LEAF, INC. 103
14.3.1 COMPANY OVERVIEW 103
14.3.2 FINANCIAL OVERVIEW 103
14.3.3 PRODUCTS/SERVICES OFFERED 103
14.3.4 KEY DEVELOPMENTS 104
14.3.5 SWOT ANALYSIS 104
14.3.6 KEY STRATEGIES 104
14.4 GREEN ROADS OF FLORIDA, LLC 105
14.4.1 COMPANY OVERVIEW 105
14.4.2 FINANCIAL OVERVIEW 105
14.4.3 PRODUCTS/SERVICES OFFERED 105
14.4.4 KEY DEVELOPMENTS 105
14.4.5 SWOT ANALYSIS 106
14.4.6 KEY STRATEGIES 106
14.5 CBD HEALTH SOLUTIONS, LLC 107
14.5.1 COMPANY OVERVIEW 107
14.5.2 FINANCIAL OVERVIEW 107
14.5.3 PRODUCTS/SERVICES OFFERED 107
14.5.4 KEY DEVELOPMENTS 107
14.5.5 SWOT ANALYSIS 108
14.5.6 KEY STRATEGIES 108
14.6 ENDOCA 109
14.6.1 COMPANY OVERVIEW 109
14.6.2 FINANCIAL OVERVIEW 109
14.6.3 PRODUCTS/SERVICES OFFERED 110
14.6.4 KEY DEVELOPMENTS 110
14.6.5 SWOT ANALYSIS 111
14.6.6 KEY STRATEGIES 111
14.7 ISODIOL INTERNATIONAL INC. 112
14.7.1 COMPANY OVERVIEW 112
14.7.2 FINANCIAL OVERVIEW 112
14.7.3 PRODUCTS/SERVICES OFFERED 112
14.7.4 KEY DEVELOPMENTS 113
14.7.5 SWOT ANALYSIS 113
14.7.6 KEY STRATEGIES 113
14.8 CV SCIENCES, INC. 114
14.8.1 COMPANY OVERVIEW 114
14.8.2 FINANCIAL OVERVIEW 114
14.8.3 PRODUCTS/SERVICES OFFERED 114
14.8.4 KEY DEVELOPMENTS 115
14.8.5 SWOT ANALYSIS 115
14.8.6 KEY STRATEGIES 115
14.9 MEDICAL MARIJUANA, INC. 116
14.9.1 COMPANY OVERVIEW 116
14.9.2 FINANCIAL OVERVIEW 116
14.9.3 PRODUCTS/SERVICES OFFERED 117
14.9.4 KEY DEVELOPMENTS 117
14.9.5 SWOT ANALYSIS 118
14.9.6 KEY STRATEGIES 118
14.10 CANOPY GROWTH CORPORATION 119
14.10.1 COMPANY OVERVIEW 119
14.10.2 FINANCIAL OVERVIEW 119
14.10.3 PRODUCTS/SERVICES OFFERED 119
14.10.4 KEY DEVELOPMENTS 120
14.10.5 SWOT ANALYSIS 120
14.10.6 KEY STRATEGIES 120
14.11 ELIXINOL GLOBAL LIMITED 121
14.11.1 COMPANY OVERVIEW 121
14.11.2 FINANCIAL OVERVIEW 121
14.11.3 PRODUCTS/SERVICES OFFERED 122
14.11.4 KEY DEVELOPMENTS 122
14.11.5 SWOT ANALYSIS 122
14.11.6 KEY STRATEGIES 122
15 APPENDIX
15.1 REFERENCES 123
15.2 RELATED REPORTS 123

LIST OF TABLES
TABLE 1 MARKET SYNOPSIS 16
TABLE 2 PRIMARY INTERVIEWS 20
TABLE 3 GLOBAL CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 33
TABLE 4 GLOBAL CANNABIDIOL (CBD) MARKET, FOR SOLID, BY REGION 2019–2030 (USD MILLION) 34
TABLE 5 GLOBAL FOR LIQUID, BY REGION 2019–2030 (USD MILLION) 34
TABLE 6 GLOBAL CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 35
TABLE 7 GLOBAL CANNABIDIOL (CBD) MARKET, FOR TINCTURE, BY REGION 2019–2030 (USD MILLION) 36
TABLE 8 GLOBAL FOR CAPSULES, BY REGION 2019–2030 (USD MILLION) 36
TABLE 9 GLOBAL FOR INHALATION (SMOKE OR VAPOR), BY REGION 2019–2030 (USD MILLION) 37
TABLE 10 GLOBAL FOR AEROSOL SPRAY, BY REGION 2019–2030 (USD MILLION) 37
TABLE 11 GLOBAL CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 38
TABLE 12 GLOBAL CANNABIDIOL (CBD) MARKET, FOR FOOD GRADE, BY REGION 2019–2030 (USD MILLION) 39
TABLE 13 GLOBAL FOR THERAPEUTIC GRADE, BY REGION 2019–2030 (USD MILLION) 39
TABLE 14 GLOBAL CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 40
TABLE 15 GLOBAL CANNABIDIOL (CBD) MARKET, FOR NEUROGENERATIVE DISORDER, BY REGION 2019–2030 (USD MILLION) 41
TABLE 16 GLOBAL FOR FIBROMYALGIA, BY REGION 2019–2030 (USD MILLION) 41
TABLE 17 GLOBAL FOR DIABETES, BY REGION 2019–2030 (USD MILLION) 42
TABLE 18 GLOBAL FOR PROTEIN BARS, BY REGION 2019–2030 (USD MILLION) 42
TABLE 19 GLOBAL FOR ENERGY DRINKS, BY REGION 2019–2030 (USD MILLION) 42
TABLE 20 GLOBAL CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 43
TABLE 21 GLOBAL CANNABIDIOL (CBD) MARKET, FOR FOOD & BEVERAGE, BY REGION 2019–2030 (USD MILLION) 44
TABLE 22 GLOBAL FOR HEALTHCARE, BY REGION 2019–2030 (USD MILLION) 44
TABLE 23 GLOBAL CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 45
TABLE 24 GLOBAL CANNABIDIOL (CBD) MARKET, FOR ORGANIC, BY REGION 2019–2030 (USD MILLION) 46
TABLE 25 GLOBAL FOR INORGANIC, BY REGION 2019–2030 (USD MILLION) 46
TABLE 26 GLOBAL CANNABIDIOL (CBD) MARKET, BY REGION 2019–2030 (USD MILLION) 48
TABLE 27 AMERICAS: CANNABIDIOL (CBD) MARKET, BY REGION 2019–2030 (USD MILLION) 49
TABLE 28 AMERICAS: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 49
TABLE 29 AMERICAS: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 50
TABLE 30 AMERICAS: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 50
TABLE 31 AMERICAS: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 50
TABLE 32 AMERICAS: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 51
TABLE 33 AMERICAS: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 51
TABLE 34 NORTH AMERICA: CANNABIDIOL (CBD) MARKET, BY COUNTRY 2019–2030 (USD MILLION) 51
TABLE 35 NORTH AMERICA: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 51
TABLE 36 NORTH AMERICA: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 52
TABLE 37 NORTH AMERICA: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 52
TABLE 38 NORTH AMERICA: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 52
TABLE 39 NORTH AMERICA: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 53
TABLE 40 NORTH AMERICA: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 53
TABLE 41 US: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 53
TABLE 42 US: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 54
TABLE 43 US: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 54
TABLE 44 US: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 54
TABLE 45 US: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 55
TABLE 46 US: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 55
TABLE 47 CANADA: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 55
TABLE 48 CANADA: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 56
TABLE 49 CANADA: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 56
TABLE 50 CANADA: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 56
TABLE 51 CANADA: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 57
TABLE 52 CANADA: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 57
TABLE 53 LATIN AMERICA: CANNABIDIOL (CBD) MARKET, BY COUNTRY 2019–2030 (USD MILLION) 57
TABLE 54 LATIN AMERICA: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 57
TABLE 55 LATIN AMERICA: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 58
TABLE 56 LATIN AMERICA: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 58
TABLE 57 LATIN AMERICA: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 58
TABLE 58 LATIN AMERICA: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 59
TABLE 59 LATIN AMERICA: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 59
TABLE 60 BRAZIL: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 59
TABLE 61 BRAZIL: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 60
TABLE 62 BRAZIL: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 60
TABLE 63 BRAZIL: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 60
TABLE 64 BRAZIL: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 61
TABLE 65 BRAZIL: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 61
TABLE 66 REST OF LATIN AMERICA: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 61
TABLE 67 REST OF LATIN AMERICA: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 62
TABLE 68 REST OF LATIN AMERICA: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 62
TABLE 69 REST OF LATIN AMERICA: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 62
TABLE 70 REST OF LATIN AMERICA: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 63
TABLE 71 REST OF LATIN AMERICA: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 63
TABLE 72 EUROPE: CANNABIDIOL (CBD) MARKET, BY REGION 2019–2030 (USD MILLION) 64
TABLE 73 EUROPE: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 64
TABLE 74 EUROPE: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 65
TABLE 75 EUROPE: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 65
TABLE 76 EUROPE: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 65
TABLE 77 EUROPE: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 66
TABLE 78 EUROPE: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 66
TABLE 79 WESTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 66
TABLE 80 WESTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 67
TABLE 81 WESTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 67
TABLE 82 WESTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 67
TABLE 83 WESTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 68
TABLE 84 WESTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 68
TABLE 85 FRANCE: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 68
TABLE 86 FRANCE: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 69
TABLE 87 FRANCE: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 69
TABLE 88 FRANCE: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 69
TABLE 89 FRANCE: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 70
TABLE 90 FRANCE: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 70
TABLE 91 ITALY: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 70
TABLE 92 ITALY: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 71
TABLE 93 ITALY: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 71
TABLE 94 ITALY: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 71
TABLE 95 ITALY: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 72
TABLE 96 ITALY: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 72
TABLE 97 GERMANY: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 72
TABLE 98 GERMANY: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 73
TABLE 99 GERMANY: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 73
TABLE 100 GERMANY: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 73
TABLE 101 GERMANY: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 74
TABLE 102 GERMANY: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 74
TABLE 103 UK: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 74
TABLE 104 UK: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 75
TABLE 105 UK: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 75
TABLE 106 UK: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 75
TABLE 107 UK: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 76
TABLE 108 UK: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 76
TABLE 109 REST OF WESTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 76
TABLE 110 REST OF WESTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 77
TABLE 111 REST OF WESTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 77
TABLE 112 REST OF WESTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 77
TABLE 113 REST OF WESTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 78
TABLE 114 REST OF WESTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 78
TABLE 115 EASTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 78
TABLE 116 EASTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 79
TABLE 117 EASTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 79
TABLE 118 EASTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 79
TABLE 119 EASTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 80
TABLE 120 EASTERN EUROPE: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 80
TABLE 121 ASIA-PACIFIC: CANNABIDIOL (CBD) MARKET, BY REGION 2019–2030 (USD MILLION) 81
TABLE 122 ASIA-PACIFIC: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 81
TABLE 123 ASIA-PACIFIC: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 81
TABLE 124 ASIA-PACIFIC: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 82
TABLE 125 ASIA-PACIFIC: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 82
TABLE 126 ASIA-PACIFIC: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 82
TABLE 127 ASIA-PACIFIC: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 83
TABLE 128 JAPAN: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 83
TABLE 129 JAPAN: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 83
TABLE 130 JAPAN: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 84
TABLE 131 JAPAN: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 84
TABLE 132 JAPAN: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 84
TABLE 133 JAPAN: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 85
TABLE 134 CHINA: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 85
TABLE 135 CHINA: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 85
TABLE 136 CHINA: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 86
TABLE 137 CHINA: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 86
TABLE 138 CHINA: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 86
TABLE 139 CHINA: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 87
TABLE 140 INDIA: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 87
TABLE 141 INDIA: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 87
TABLE 142 INDIA: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 88
TABLE 143 INDIA: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 88
TABLE 144 INDIA: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 88
TABLE 145 INDIA: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 89
TABLE 146 REST OF ASIA-PACIFIC: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 89
TABLE 147 REST OF ASIA-PACIFIC: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 89
TABLE 148 REST OF ASIA-PACIFIC: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 90
TABLE 149 REST OF ASIA-PACIFIC: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 90
TABLE 150 REST OF ASIA-PACIFIC: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 90
TABLE 151 REST OF ASIA-PACIFIC: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 91
TABLE 152 MIDDLE EAST & AFRICA: CANNABIDIOL (CBD) MARKET, BY FORM 2019–2030 (USD MILLION) 91
TABLE 153 MIDDLE EAST & AFRICA: CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019–2030 (USD MILLION) 91
TABLE 154 MIDDLE EAST & AFRICA: CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019–2030 (USD MILLION) 92
TABLE 155 MIDDLE EAST & AFRICA: CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019–2030 (USD MILLION) 92
TABLE 156 MIDDLE EAST & AFRICA: CANNABIDIOL (CBD) MARKET, BY END USE 2019–2030 (USD MILLION) 92
TABLE 157 MIDDLE EAST & AFRICA: CANNABIDIOL (CBD) MARKET, BY SOURCE 2019–2030 (USD MILLION) 93

LIST OF FIGURES
FIGURE 1 GLOBAL CBD MARKET: MARKET STRUCTURE 18
FIGURE 2 RESEARCH PROCESS OF MRFR 19
FIGURE 3 TOP DOWN & BOTTOM UP APPROACH 22
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL CANNABIDIOL (CBD) MARKET 23
FIGURE 5 SUPPLY CHAIN: GLOBAL CANNABIDIOL (CBD) MARKET 27
FIGURE 6 PORTER’S FIVE FORCES ANALYSIS OF THE GLOBAL CANNABIDIOL (CBD) MARKET 29
FIGURE 7 GLOBAL CANNABIDIOL (CBD) MARKET, BY FORM 2019 & 2030 (USD MILLION) 33
FIGURE 8 GLOBAL CANNABIDIOL (CBD) MARKET, BY ROUTES OF ADMINISTRATION 2019 & 2030 (USD MILLION) 36
FIGURE 9 GLOBAL CANNABIDIOL (CBD) MARKET, BY PRODUCT 2019 & 2030 (USD MILLION) 39
FIGURE 10 GLOBAL CANNABIDIOL (CBD) MARKET, BY APPLICATION 2019 & 2030 (USD MILLION) 41
FIGURE 11 GLOBAL CANNABIDIOL (CBD) MARKET, BY END USE 2019 & 2030 (USD MILLION) 44
FIGURE 12 GLOBAL CANNABIDIOL (CBD) MARKET, BY SOURCE 2019 & 2030 (USD MILLION) 46
FIGURE 13 GLOBAL CANNABIDIOL (CBD) MARKET SHARE, BY REGION2019 (%) 48
FIGURE 14 AMERICAS: CANNABIDIOL (CBD) MARKET SHARE, BY REGION 2019 (%) 49
FIGURE 15 EUROPE: CANNABIDIOL (CBD) MARKET SHARE, BY REGION 2019 (%) 64
FIGURE 16 COMPANY MARKET SHARE ANALYSIS, 2019 (%) 94


    お問合せフォーム

    • *のある項目は必須項目です。

    • レポートのタイトルは自動で入ります。

    • 無料サンプルはご購入を検討されている方向けのレポート形式等確認用資料です。
      重要記述や数値は記載されていません。予めご了承ください。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com